Post-approval studies (Phase 4)Not Yet RecruitingNCT07686042
What this trial is testing
Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis
Who this might be right for
Autoimmune Encephalitis (AE)Autoimmune Cerebellitis
Beijing Tiantan Hospital 12